Spanish Industry Calls For Dedicated Orphan Drug Reimbursement Route
Executive Summary
The current system means Spain is not a priority launch country.
You may also be interested in...
Calls Grow For New ‘Hispa-NICE’ HTA Agency In Spain
EU stimulus funding marks opportunity to establish health technology appraisal agency in Spain.
England: HTA Body NICE Makes Big RWE Push
England’s health technology appraisal institute, NICE, has published its real-world evidence framework.
Smaller EU Countries Call for More Comparative Trials
More should be done to incentivize comparative clinical trials so as to allow better decisions on drug pricing to be taken, said Austria’s representative at a recent meeting of EU health ministers.